ANCA-associated vasculitides-lessons from the adult literature

Pediatric Nephrology

Volumn 25, Issue 8, 2010, Pages 1397-1407

  Vamvakopoulos, Joannis ^a   Savage, Caroline O ^a   Harper, Lorraine ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Microscopic polyangiitis polyarteritis; Paediatric; Vasculitis; Wegener's granulomatosis

Indexed keywords

15 DEOXYSPERGUALIN; ALEMTUZUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID; NEUTROPHIL CYTOPLASMIC ANTIBODY; RITUXIMAB; ANTIBODY; ANTIGEN;

ADRENAL INSUFFICIENCY; ANCA ASSOCIATED VASCULITIS; BONE DEMINERALIZATION; BONE MARROW SUPPRESSION; CLINICAL EXAMINATION; DISABILITY; DRUG HYPERSENSITIVITY; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTROINTESTINAL DISEASE; GONAD DYSFUNCTION; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; LABORATORY DIAGNOSIS; LIVER TOXICITY; MEDICAL LITERATURE; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PEDIATRICIAN; PEPTIC ULCER; PRIORITY JOURNAL; RARE DISEASE; REVIEW; THROMBOSIS; URINARY TRACT CARCINOMA; ADULT; DIAGNOSTIC USE; IMMUNOLOGY; PUBLICATION; SYSTEMIC VASCULITIS; VASCULITIS;

ADULT; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGENS; HUMANS; IMMUNOGLOBULINS; PUBLICATIONS; SYSTEMIC VASCULITIS; VASCULITIS;

EID: 77954427650     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1496-z     Document Type: Review

References (90)

1. S Ozen 2005 Problems in classifying vasculitis in children Pediatr Nephrol 20 1214 1218 10.1007/s00467-005-1911-z 15880268 (Pubitemid 41222964)
2. J Jennette R Falk 2000 Do vasculitis categorization systems really matter? Curr Rheumatol Rep 2 430 438 10.1007/s11926-000-0044-4 1:STN:280:DC%2BD3M7ktVajsA%3D%3D 11123094
3. JK Rao NB Allen T Pincus 1998 Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis Ann Intern Med 129 345 352 1:STN:280:DyaK1czpsl2qug%3D%3D 9735061
4. J Fries G Hunder D Bloch B Michel W Arend L Calabrese A Fauci R Leavitt J Lie RJ Lightfoot A Masi DJ McShane JA Mills MB Stevens SL Wallace NJ Zvaifler 1990 The American College of Rheumatology 1990 criteria for the classification of vasculitis: summary Arthritis Rheum 33 1135 1136 1:STN:280: DyaK3czlvVyqug%3D%3D 2202312 (Pubitemid 20273299)
5. JC Jennette RJ Falk K Andrassy PA Bacon J Churg WL Gross EC Hagen GS Hoffman GG Hunder CGM Kallenberg RT McCluskey RA Sinico AJ Rees LA van Es R Waldherr A Wiik 1994 Nomenclature of systemic vasculitides: the proposal of an International Consensus Conference Arthritis Rheum 37 187 192 10.1002/art.1780370206 1:STN:280:DyaK2c7nsF2mug%3D%3D 8129773
6. S Sørensen O Slot N Tvede J Petersen 2000 A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature Ann Rheum Dis 59 478 482 10.1136/ard.59.6.478 10834866 (Pubitemid 30395606)
7. N Murali R George G John S Chandi M Jacob L Jeyaseelan P Thomas C Jacob 2002 Problems of classification of Henoch Schönlein purpura: an Indian perspective Clin Exp Dermatol 27 260 263 10.1046/j.1365-2230.2002.01063.x 1:STN:280:DC%2BD38zptFCqtw%3D%3D 12139664 (Pubitemid 34985116)
8. I Bruce A Bell 1997 A comparison of two nomenclature systems for primary systemic vasculitis Br J Rheumatol 36 453 458 10.1093/rheumatology/36.4.453 1:STN:280:DyaK2szgtlWjug%3D%3D 9159539
9. SS Uppal MA Hussain HA Al-Raqum MR Nampoory K Al-Saeid A Al-Assousi M Abraham AN Malaviya 2006 Henoch-Schonlein's purpura in adults versus children/adolescents: A comparative study Clin Exp Rheumatol 24 S26 30 1:STN:280:DC%2BD28vks1SjsQ%3D%3D 16859592
10. S Ozen N Ruperto M Dillon A Bagga K Barron J Davin T Kawasaki C Lindsley R Petty A Prieur A Ravelli P Woo 2006 EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides Ann Rheum Dis 65 936 941 10.1136/ard.2005.046300 1:STN:280:DC%2BD28zlsVKhtw%3D%3D 16322081
11. E Matteson 2000 Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schönlein, Wegener, Churg and Strauss, Horton, Takayasu, Behçet and Kawasaki Arthritis Care Res 13 237 245 10.1002/1529-0131(200008)13:4<237::AID-ANR8>3.0.CO;2-J 1:STN:280:DC%2BD3srlsF2ruw%3D%3D 14635278
12. S Grisaru GW Yuen PM Miettunen LA Hamiwka 2009 Incidence of Wegener's granulomatosis in children J Rheumatol 10.3899/jrheum.090688 20032105
13. J Gardner-Medwin P Dolezalova C Cummins TR Southeood 2002 Incidence of Henoch-Schönlein purpura, Kawasaki disease and rare vasculitides in children of different ethnic origins Lancet 360 1197 1202 10.1016/S0140-6736(02) 11279-7 12401245 (Pubitemid 35232718)
14. RA Watts A Al-Taiar DG Scott AJ Macgregor 2009 Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database Arthritis Rheum 61 1412 1416 10.1002/art.24544 19790134
15. AJ Mohammad LT Jacobsson KW Westman G Sturfelt M Segelmark 2009 Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa Rheumatology (Oxford) 48 1560 1565 10.1093/rheumatology/kep304
16. J Zwerina G Eger M Englbrecht B Manger G Schett 2008 Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients Semin Arthritis Rheum 39 108 115 10.1016/j.semarthrit.2008. 05.004 18639318
17. A Knight S Sandin J Askling 2008 Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease Arthritis Rheum 58 302 307 10.1002/art.23157 18163522
18. MC Slot MG Sokolowska KG Savelkouls RG Janssen JG Damoiseaux JW Cohen Tervaert 2008 Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis Clin Immunol 128 39 45 10.1016/j.clim.2008.03.506 1:CAS:528:DC%2BD1cXnsFOlsbY%3D 18448390
19. 1-antitrypsin as a determinant of outcome in Pr3-ANCA-positive vasculitis Kidney Int 48 844 850 10.1038/ki.1995.360 1:CAS:528: DyaK2MXosF2nt7k%3D 7474674
20. MH Biezeveld J Geissler GJ Weverling IM Kuipers J Lam J Ottenkamp TW Kuijpers 2006 Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease Arthritis Rheum 54 369 376 10.1002/art.21529 1:CAS:528:DC%2BD28XhsVentr8%3D 16385529 (Pubitemid 43122222)
21. L Kamesh JM Heward JM Williams SC Gough CO Savage L Harper 2007 Mannose-binding lectin gene polymorphisms in a cohort study of ANCA-associated small vessel vasculitis Rheumatology (Oxford) 46 1076 1078 10.1093/rheumatology/ kem099 1:CAS:528:DC%2BD2sXosVSjt7w%3D (Pubitemid 47050606)
22. M Fujieda M Hattori H Kurayama Y Koitabashi 2002 Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment J Am Soc Nephrol 13 437 445 1:CAS:528:DC%2BD38XhtlWju7g%3D 11805173
23. H Sato M Hattori M Fujieda S Sugihara H Inomata M Hoshi S Miyamoto 2000 High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil J Clin Endocrinol Metab 85 4270 4273 10.1210/jc.85.11.4270 1:CAS:528:DC%2BD3cXotlWmsrk%3D 11095466 (Pubitemid 32055385)
24. CA Stegeman JW Cohen Tervaert WJ Sluiter WL Manson PE de Jong CG Kallenberg 1994 Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegner's granulomatosis Ann Intern Med 120 74 75
25. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG: Dutch Co-Trimoxazole Wegener Study Group 1996 Trimethoprim-sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis N Engl J Med 335 16 20 10.1056/ NEJM199607043350103 (Pubitemid 26230808)
26. R Kain M Exner R Brandes R Ziebermayr D Cunningham CA Alderson A Davidovits I Raab R Jahn O Ashour S Spitzauer G Sunder-Plassmann M Fukuda P Klemm AJ Rees D Kerjaschki 2008 Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis Nat Med 14 1088 1096 10.1038/nm.1874 1:CAS:528:DC%2BD1cXht1Slu7rL 18836458
27. E Hagen M Daha J Hermans K Andrassay E Csernok G Gaskin P Lesavre J Ludemann N Rasmussen R Sinico A Wiik F van der Woude 1998 Diagnostic value of standardised assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis Kidney Int 53 743 753 10.1046/j.1523-1755.1998.00807.x 1:STN:280:DyaK1c7mvVSlsQ%3D%3D 9507222 (Pubitemid 28124291)
28. PJ Bansal MC Tobin 2004 Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement Ann Allergy Asthma Immunol 93 398 401 10.1016/S1081-1206(10)61400-7 15521377
29. F Silva U Specks S Sethi M Irazabal FC Fervenza 2009 Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis Am J Kidney Dis 54 542 545 10.1053/j.ajkd.2009.02.016 19395136
30. H Xiao P Heeringa P Hu Z Liu M Zhao Y Aratani N Maeda RJ Falk JC Jennette 2002 Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice J Clin Invest 110 955 963 1:CAS:528:DC%2BD38XnslSksbg%3D 12370273
31. H Xiao P Heeringa Z Liu D Huugen P Hu N Maeda RJ Falk JC Jennette 2005 The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies Am J Pathol 167 39 45 1:CAS:528: DC%2BD2MXms1eisbo%3D 15972950
32. A Schreiber H Xiao RJ Falk JC Jennette 2006 Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies J Am Soc Nephrol 17 3355 3364 10.1681/ASN.2006070718 17108314 (Pubitemid 44865278)
33. L Harper P Cockwell D Adu C Savage 2001 Neutrophil priming and apoptosis in ANCA-associated vasculitis Kidney Int 59 1729 1738 10.1046/j.1523-1755.2001. 0590051729.x 1:CAS:528:DC%2BD3MXjs1ehsLs%3D 11318943 (Pubitemid 32336787)
34. A Muller Kubold G Mesander C Stegeman C Kallenberg J Cohen Tervaert 1998 Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides? Clin Exp Immunol 114 491 499 10.1046/j.1365-2249.1998.00748.x (Pubitemid 28539612)
35. D Huugen H Xiao A van Esch RJ Falk CJ Peutz-Kootstra WA Buurman JW Tervaert JC Jennette P Heeringa 2005 Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha Am J Pathol 167 47 58 1:CAS:528:DC%2BD2MXms1eisbs%3D 15972951
36. RJ Falk RS Terrell LA Charles JC Jennette 1990 Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro Proc Natl Acad Sci USA 87 4115 4119 10.1073/pnas.87.11.4115 1:CAS:528:DyaK3cXktlylu7w%3D 2161532 (Pubitemid 20217992)
37. JM Williams L Kamesh CO Savage 2005 Translating basic science into patient therapy for ANCA-associated small vessel vasculitis Clin Sci (Lond) 108 101 112 10.1042/CS20040232 (Pubitemid 40175403)
38. D Reumaux TW Kuijpers PL Hordijk P Duthilleul D Roos 2003 Involvement of Fcgamma receptors and beta2 integrins in neutrophil activation by anti-proteinase-3 or anti-myeloperoxidase antibodies Clin Exp Immunol 134 344 350 10.1046/j.1365-2249.2003.02280.x 1:CAS:528:DC%2BD3sXpsFWqsL8%3D 14616797 (Pubitemid 37376426)
39. SL Nolan N Kalia GB Nash D Kamel P Heeringa CO Savage 2008 Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo J Am Soc Nephrol 19 973 984 10.1681/ASN.2007111166 1:CAS:528:DC%2BD1cXmtlOgs7g%3D 18305123
40. P Lamprecht 2005 Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides Clin Exp Immunol 141 201 210 10.1111/j.1365-2249.2005.02808.x 1:CAS:528:DC%2BD2MXotFaktLk%3D 15996183 (Pubitemid 41003343)
41. R Giscombe XB Wang M Kakoulidou AK Lefvert 2006 Characterization of the expanded T-cell populations in patients with Wegener's granulomatosis J Intern Med 260 224 230 10.1111/j.1365-2796.2006.01688.x 1:CAS:528:DC%2BD28XhtVOgur3P 16918819 (Pubitemid 44253635)
42. J Voswinkel A Mueller JA Kraemer P Lamprecht K Herlyn K Holl-Ulrich AC Feller S Pitann A Gause WL Gross 2006 B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions Ann Rheum Dis 65 859 864 10.1136/ard.2005.044909 1:STN:280:DC%2BD28zlsVKhsg%3D%3D 16291812
43. D Hooke D Gee R Atkins 1987 Leukocyte analysis using monoclonal antibodies in glomerulonephritis Kidney Int 31 964 972 10.1038/ki.1987.93 1:STN:280:DyaL2s3islSlug%3D%3D 3495689
44. ER Popa CA Stegeman NA Bos CG Kallenberg JW Tervaert 1999 Differential B-and T-cell activation in Wegener's granulomatosis J Allergy Clin Immunol 103 885 894 10.1016/S0091-6749(99)70434-3 1:STN:280:DyaK1M3mt1Gmug%3D%3D 10329824 (Pubitemid 29297593)
45. DA Culton MW Nicholas DO Bunch QL Zhen TB Kepler MA Dooley C Mohan PH Nachman SH Clarke 2007 Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss J Clin Immunol 27 53 68 10.1007/s10875-006-9051-1 1:CAS:528:DC%2BD2sXhsVyqurk%3D 17195045 (Pubitemid 46224934)
46. DA Cabral AG Uribe S Benseler KM O'Neil PJ Hashkes G Higgins AS Zeft DJ Lovell DJ Kingsbury A Stevens D McCurdy P Chira L Abramson T Arkachaisri S Campillo A Eberhard AO Hersh AM Huber S Kim M Klein-Gitelman DM Levy SC Li T Mason EM Dewitt E Muscal L Nassi A Reiff K Schikler NG Singer D Wahezi A Woodward 2009 Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood Arthritis Rheum 60 3413 3424 10.1002/art.24876 19877069
47. JD Akikusa R Schneider EA Harvey D Hebert PS Thorner RM Laxer ED Silverman 2007 Clinical features and outcome of pediatric Wegener's granulomatosis Arthritis Rheum 57 837 844 10.1002/art.22774 1:STN:280: DC%2BD2szlt12rug%3D%3D 17530684 (Pubitemid 46932091)
48. M Hattori H Kurayama Y Koitabashi 2001 Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children J Am Soc Nephrol 12 1493 1500 1:STN:280:DC%2BD3MzosF2nuw%3D%3D 11423578
49. VM Belostotsky V Shah MJ Dillon 2002 Clinical features in 17 paediatric patients with Wegener granulomatosis Pediatr Nephrol 17 754 761 10.1007/s00467-002-0914-2 12215830 (Pubitemid 36097360)
50. SE Lane RA Watts L Shepstone DG Scott 2005 Primary systemic vasculitis: clinical features and mortality Q J Med 98 97 111 1:STN:280: DC%2BD2M%2FksVGmtg%3D%3D
51. M Rottem A Fauci C Hallahan G Kerr R Lebovics R Leavitt G Hoffman 1993 Wegener granulomatosis in children and adolescents: clinical presentation and outcome J Pediatr 122 26 31 10.1016/S0022-3476(05)83482-1 1:STN:280: DyaK3s7isVarsw%3D%3D 8419611 (Pubitemid 23010679)
52. C Kallenberg P Heeringa C Stegeman 2006 Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides Nat Clin Pract Rheumatol 2 661 670 10.1038/ncprheum0355 1:CAS:528:DC%2BD28XhtlentL3I 17133251 (Pubitemid 44830855)
53. PM Stassen RP Derks CG Kallenberg CA Stegeman 2008 Venous thromboembolism in ANCA-associated vasculitis-incidence and risk factors Rheumatology (Oxford) 47 530 534 10.1093/rheumatology/ken035 1:STN:280:DC%2BD1c7pslGhtw%3D%3D
54. PA Merkel GH Lo JT Holbrook AK Tibbs NB Allen JC Davis Jr GS Hoffman WJ McCune EW St Clair U Specks R Spiera M Petri JH Stone 2005 Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study Ann Intern Med 142 620 626 15838068
55. RA Luqmani PA Bacon RJ Moots BA Janssen A Pall P Emery D Adu 1994 Birmingham Vasculitis Activity Score (BVAS) in systemic necrotising vasculitis Q J Med 87 671 678 1:STN:280:DyaK2M7itVClsg%3D%3D
56. R Birck WH Schmitt IA Kaelsch FJ van der Woude 2006 Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review Am J Kidney Dis 47 15 23 10.1053/j.ajkd.2005.09. 022 16377381 (Pubitemid 41828262)
57. C Mukhtyar L Guillevin MC Cid B Dasgupta K de Groot W Gross T Hauser B Hellmich D Jayne CG Kallenberg PA Merkel H Raspe C Salvarani DG Scott C Stegeman R Watts K Westman J Witter H Yazici R Luqmani 2009 EULAR recommendations for the management of primary small and medium vessel vasculitis Ann Rheum Dis 68 310 317 10.1136/ard.2008.088096 1:CAS:528:DC%2BD1MXjs1WitLw%3D 18413444
58. C Mukhtyar O Flossmann B Hellmich P Bacon M Cid JW Cohen-Tervaert WL Gross L Guillevin D Jayne A Mahr PA Merkel H Raspe D Scott J Witter H Yazici RA Luqmani 2008 Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism Systemic Vasculitis Task Force Ann Rheum Dis 67 1004 1010 10.1136/ard.2007.071936 1:CAS:528:DC%2BD1cXoslChtr4%3D 17911225 (Pubitemid 351956664)
59. K de Groot L Harper DR Jayne LF Flores Suarez G Gregorini WL Gross R Luqmani CD Pusey N Rasmussen RA Sinico V Tesar P Vanhille K Westman CO Savage EUVAS (European Vasculitis Study Group) 2009 Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis. A randomized trial Ann Intern Med 150 670 680 19451574
60. D Jayne N Rasmussen K Andrassy P Bacon JW Tervaert J Dadoniene A Ekstrand G Gaskin G Gregorini K de Groot W Gross EC Hagen E Mirapeix E Pettersson C Siegert A Sinico V Tesar K Westman C Pusey 2003 A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 36 44 10.1056/NEJMoa020286 1:CAS:528: DC%2BD3sXltFGku70%3D 12840090 (Pubitemid 36765101)
61. DR Jayne G Gaskin N Rasmussen D Abramowicz F Ferrario L Guillevin E Mirapeix CO Savage RA Sinico CA Stegeman KW Westman FJ van der Woude RA de Lind van Wijngaarden CD Pusey 2007 Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 2180 2188 10.1681/ASN.2007010090 1:CAS:528:DC%2BD2sXotlWnur0%3D 17582159 (Pubitemid 47041083)
62. E Tizard M Dillon 1991 Plasmapheresis in childhood Care Critically Ill 7 51 56
63. WE DM K Tullus 2007 Childhood vasculitis and plasma exchange Eur J Pediatr 166 145 151
64. K de Groot N Rasmussen PA Bacon JW Tervaert C Feighery G Gregorini WL Gross R Luqmani DR Jayne 2005 Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 52 2461 2469 10.1002/art.21142 16052573 (Pubitemid 41117433)
65. C Pagnoux A Mahr MA Hamidou JJ Boffa M Ruivard JP Ducroix X Kyndt F Lifermann T Papo M Lambert J Le Noach M Khellaf D Merrien X Puechal S Vinzio P Cohen L Mouthon JF Cordier L Guillevin 2008 Azathioprine or methotrexate maintenance for ANCA-associated vasculitis N Engl J Med 359 2790 2803 10.1056/NEJMoa0802311 1:CAS:528:DC%2BD1cXhsFCnt7bK 19109574
66. T Hiemstra M Walsh K De Groot T Hauser A Mahr C Pagnoux L Harper C Savage V Tesar I Neumann K Wissing W Schmitt D Jayne 2009 Randomized trial of mycophenolate mofetil versus azathioprine for maintenance therapy in ANCA-associated vasculitis APMIS 117 suppl 127 177
67. J Brunner M Freund M Prelog E Binder M Sailer-Hoeck T Jungraithmayr C Huemer C Sergi LB Zimmerhackl 2009 Successful treatment of severe juvenile microscopic polyangiitis with rituximab Clin Rheumatol 28 997 999 10.1007/s10067-009-1177-0 1:STN:280:DC%2BD1MvovVKrtw%3D%3D 19390907
68. AM Patel TJ Lehman 2008 Rituximab for severe refractory pediatric Wegener granulomatosis J Clin Rheumatol 14 278 280 10.1097/RHU.0b013e3181886064 18824926
69. RB Jones AJ Ferraro AN Chaudhry P Brogan AD Salama KG Smith CO Savage DR Jayne 2009 A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 60 2156 2168 10.1002/art.24637 1:CAS:528:DC%2BD1MXptlKrsLo%3D 19565480
70. D Eleftheriou M Melo SD Marks K Tullus J Sills G Cleary P Dolezalova S Ozen C Pilkington P Woo N Klein MJ Dillon PA Brogan 2009 Biologic therapy in primary systemic vasculitis of the young Rheumatology (Oxford) 48 978 986 10.1093/rheumatology/kep148 1:CAS:528:DC%2BD1MXptVagurk%3D
71. M Walsh D Jayne 2007 Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future Kidney Int 72 676 682 10.1038/sj.ki.5002395 1:CAS:528:DC%2BD2sXpvFWlsLY%3D 17609693 (Pubitemid 47373785)
72. AJ Ferraro MT Drayson CO Savage IC MacLennan 2008 Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with rituximab Eur J Immunol 38 292 298 10.1002/eji.200737557 1:CAS:528:DC%2BD1cXhvVOnt7o%3D 18085668
73. AJ Ferraro SW Smith D Neil CO Savage 2008 Relapsed Wegener's granulomatosis after rituximab therapy-B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood Nephrol Dial Transplant 23 3030 3032 10.1093/ndt/gfn318 18586761
74. RB Jones M Walsh D Jayne EUVAS 2008 Randomised trial of rituximab versus cyclophosphamide for ANCA-associated vasculitis J Am Soc Nephrol 19 61A
75. NM Wilkinson E Erendzhinova A Zeft DA Cabral 2006 Infliximab as rescue therapy in three cases of paediatric Wegener's granulomatosis Rheumatology (Oxford) 45 1047 1048 10.1093/rheumatology/kel172 1:STN:280: DC%2BD28vjvVertg%3D%3D (Pubitemid 44283068)
76. WGET Research Group 2005 Etanercept plus standard therapy for Wegener's granulomatosis N Engl J Med 352 351 361 10.1056/NEJMoa041884
77. V Martinez P Cohen C Pagnoux S Vinzio A Mahr L Mouthon L Sailler C Delaunay A Sadoun L Guillevin 2008 Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients Arthritis Rheum 58 308 317 10.1002/art.23147 1:CAS:528:DC%2BD1cXhslOjur8%3D 18163506
78. O Flossmann B Baslund A Bruchfeld JW Cohen Tervaert C Hall P Heinzel B Hellmich RA Luqmani K Nemoto V Tesar DR Jayne 2009 Deoxyspergualin in relapsing and refractory Wegener's granulomatosis Ann Rheum Dis 68 1125 1130 10.1136/ard.2008.092429 1:CAS:528:DC%2BD1MXovVCmsro%3D 18713783
79. M Walsh A Chaudhry DR Jayne 2008 Long-term follow-up of relapsing/refractory ANCA associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H) Ann Rheum Dis 67 1322 1327 10.1136/ard.2007.081661 1:CAS:528:DC%2BD1cXhtFGhtL%2FM 18055469
80. WH Schmitt EC Hagen I Neumann R Nowack LF Flores-Suarez FJ van der Woude 2004 Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients Kidney Int 65 1440 1448 10.1111/j.1523-1755.2004.00534.x 1:CAS:528:DC%2BD2cXjtF2js7g%3D 15086487 (Pubitemid 38406986)
81. A Turnbull 2009 Harper L (2009) Adverse effects of therapy for ANCA-associated vasculitis Best Practice Res 23 391 401 10.1016/j.berh.2009.04. 002
82. MA Little P Nightingale CA Verburgh T Hauser K De Groot C Savage DR Jayne L Harper 2009 Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis Ann Rheum Dis 10.1136/ard.2009.109389 19574233
83. C Charlier C Henegar O Launay C Pagnoux A Berezne B Bienvenu P Cohen L Mouthon L Guillevin 2009 Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients Ann Rheum Dis 68 658 663 10.1136/ard.2008.088302 1:STN:280:DC%2BD1M3ns1Sksg%3D%3D 18504289
84. L Harper CO Savage 2005 ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients Rheumatology (Oxford) 44 495 501 10.1093/rheumatology/keh522 1:STN:280:DC%2BD2M7ks1ymsQ%3D%3D (Pubitemid 41511141)
85. JB Chung K Armstrong JS Schwartz D Albert 2000 Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy Arthritis Rheum 43 1841 1848 10.1002/1529-0131(200008)43:8<1841::AID-ANR21>3.0.CO;2-Q 1:STN:280:DC%2BD3cvisVantQ%3D%3D 10943875 (Pubitemid 30640940)
86. B Hellmich A Schnabel W Gross 1999 G-CSF treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis Arthritis Rheum 42 1752 1756 10.1002/1529-0131(199908)42:8<1752::AID- ANR26>3.0.CO;2-6 1:CAS:528:DyaK1MXlsFyntrc%3D 10446877 (Pubitemid 30263646)
87. PM Stassen JS Sanders CG Kallenberg CA Stegeman 2008 Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis Nephrol Dial Transplant 23 654 658 10.1093/ndt/gfm640 17913738 (Pubitemid 351767630)
88. A Holvast C Stegeman C Benne A Huckriede J Wilschut A Palache C Kallenberg M Bijl 2009 Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination Ann Rheum Dis 68 873 878 10.1136/ard.2008.092924 1:CAS:528:DC%2BD1MXotVCjtb8%3D 18625625
89. O Flossmann A Berden K de Groot L Harper C Heijl P Hoglund D Jayne R Luqmani A Mahr C Mukhtyar C Pusey N Rasmussen K Westmann 2009 Longterm survival of ANCA-associated vasculitis APMIS 117 Suppl s127 139
90. S Ozen J Anton N Arisoy A Bakkaloglu N Besbas P Brogan J Garcia-Consuegra P Dolezalova F Dressler A Duzova VP Ferriani MO Hilario M Ibanez-Rubio O Kasapcopur W Kuis TJ Lehman D Nemcova S Nielsen SK Oliveira K Schikler F Sztajnbok MT Terreri F Zulian P Woo 2004 Juvenile polyarteritis: results of a multicenter survey of 110 children J Pediatr 145 517 522 10.1016/j.jpeds.2004. 06.046 15480378 (Pubitemid 39345990)